Novo Nordisk Financial Calendar. Nvo) is a heavyweight in the biotech industry, having been in the game for over a century. Hardly for the first time in recent weeks and months, novo nordisk ( nvo 2.08%) had a good trading session on the stock market monday.
Novo nordisk a/s has a one year low of $75.56 and a one year high of $138.28. The stock has a market capitalization of $577.19 billion, a p/e ratio of 47.55, a.
Content S Introducing Novo Nordisk Strategic Aspirations Key Risks Management Consolidated Statements Additional.
This change lagged the s&p.
Purchase Of Other Financial Assets Repayment Of Borrowings Proceeds From Borrowings 31 Dec 2020 Other Biopharm Average Number Of Diluted Shares Outstanding (Million) Q1.
Financial ratios and metrics for novo nordisk a/s (nvo).
View Nvo Financial Statements In Full.
Images References :
Purchase Of Other Financial Assets Repayment Of Borrowings Proceeds From Borrowings 31 Dec 2020 Other Biopharm Average Number Of Diluted Shares Outstanding (Million) Q1.
It boasts a vast pipeline of innovative drugs,.
This Change Lagged The S&Amp;P.
Look out for nvo’s next earnings release expected on may 02, 2024.